Tscan therapeutics announces upcoming presentation at the jefferies global healthcare conference

Waltham, mass., may 28, 2025 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biotechnology company focused on the development of t cell receptor (tcr)-engineered t cell (tcr-t) therapies for the treatment of patients with cancer, today announced that the company will present at the jefferies global healthcare conference being held at the marriott marquis in new york, ny on wednesday, june 4, 2025 at 4:55 p.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking